by Lisa Nadal | Sep 15, 2022 | 2022, Press Releases, Scientific
The study shows selective tumor uptake of IL12-7NP2 and potent antitumor activity as single agent and in combination with immune checkpoint inhibitors. The product is well tolerated when administered to non-human primates. More detailsby m.romi | Jul 25, 2022 | 2022, Press Releases, Scientific
More detailsby mfantozzi | Feb 17, 2022 | 2022, Press Releases, Scientific
More detailsby mfantozzi | Jan 7, 2022 | 2022, Press Releases, Scientific
More info hereby last | Nov 24, 2021 | 2022, Press Releases
20211124_PR_Philochem_Janssen_DELby mfantozzi | Nov 24, 2021 | 2021, Press Releases, Scientific
More datails
Recent Comments